Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Lev Gorfinkel(Boston Children's Hospital), Muna Qayed(Children's Healthcare of Atlanta), Kayla Betz(Boston Children's Hospital), Nosha Farhadfar(University of Florida Health), Leslie S. Kean(Boston Children's Hospital), Michael Grimley(Cincinnati Children's Hospital Medical Center), Sharmila Raghunandan(Emory University), Amelia Langston(CancerCare Manitoba), John Horan(Emory University), Sung Won Choi(University of Michigan), David A. Jacobsohn(Children's National), Nahal Lalefar(University of California, San Francisco), Shalini Shenoy(Washington University in St. Louis), Jeffrey Davis(BC Children's Hospital), Roger Giller(Center for Cancer and Blood Disorders), Andrew C Harris(Memorial Sloan Kettering Cancer Center), Michael A Pulsipher(Primary Children's Hospital), Aleksandra Petrovic(Seattle Children's Hospital), Kirk R Schultz(University of British Columbia), Gregory A Yanik(University of Michigan), Bruce R Blazar(University of Minnesota), Benjamin Watkins(Emory University), Kyle Hebert(Dana-Farber Cancer Institute), Alison Yu(Boston Children's Hospital), Donna Neuberg(Otsuka (Japan)), Christine Duncan(Boston Children's Hospital), Brandi Bratrude(Boston Children's Hospital)
Cited by 7
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k